热议!医生质疑:医院裁员不裁科研岗,却把临床业务人员赶走了!不搞科研,首先被裁,你会搞吗?医学科研很重要,对经费动贪念,不可饶恕

2026-02-05 梅斯头条 MedSci原创 发表于上海

医生质疑:医院裁员不裁科研岗,却把临床岗位赶走了

医生质疑:医院裁员不裁科研岗,

把临床业务人员都赶走了!

118日,华东某大型医院一名医生发文透露了一种十分奇怪的情况。

他指出:我们医院优化了一批医生……但是难以理解的是,医院裁员不裁科研岗把业务牛马都赶走了,这样裁员,临床工作谁来干活科研做到飞起到底能给医院带来多少绩效和收入呀,这是不是本末倒置了

图片

医院裁员不裁科研岗,却把忙碌于临床业务的一批人给优化了,这种情况并不少见,近期很多医生都吐槽了类似的事情。

120日,四川一名医生表示:“给大家说一说我们儿科的操作。科室以前本来有10个有证有编制的医生(儿科收入绩效一直全院垫底),因为一些原因陆陆续续三年内走了五个于是,医院开始搞就业见习这种操作,差不多招收五六个人,一个月工资3000(没有任何保险),也没有绩效,勉强有点病历费用。然后给每个主治医生分一两个见习助手,结果呢科室依旧正常运行见习助手就负责收病人写病历办出院,主管医生负责下医嘱检查修改病历,就这样一直bug所以你看看,这已经给中层领导、院领导留下了一个深刻的认知:你就算把科室医生裁员一半,科室也能正常运行!

“相反,会搞科研的医生就不能优化了,不但不能优化,还得多招,为什么?现在医院靠业务收入少了,更加看重另一种创收渠道,那就是靠更多的科研项目多申请经费,经费申请得越多越好!这就是我们医院的现状。”

22日,北京某医院一名医生匿名透露:“知道为什么裁员只裁临床岗,不裁科研岗吗?现实很扎心!因为现在看病直接化验,化验单Ai就能看,临床医生没啥稀缺价值了,除非你会高大上的手术。另外,现在临床一线1个人可以干2个人,甚至干3个人的活,这有天然的职业要求,必须救死扶伤,必须干,有活你就得干,不要讲钱要讲奉献,你不干出了事就得你负责。举个生动的例子,原来有10头牛耕地,发现杀了两头好像也不影响耕地,那就再杀两头,没想到牛更加卖力耕地了,就算现在只有6头牛了,依旧耕得完。

“那么,为什么不裁科研岗呢?本质就是医院没钱了,科研是申请经费的一个非常重要的由头,就算有些医院没能真正搞出重磅的科研成果,但就是需要喊得震天响。再加上科研岗医生也能干点临床的活,所以你要是优先把科研岗裁了,年底工作汇报会很难看的。而且要是现在裁掉科研岗,等经济缓和了,再招一批回来,从头开始做课题,要花很多时间和精力,太耽误事了。总之,不是不裁科研岗,而是医院在他们身上的沉没成本太高,能不动就先不动,临床医生就不同了,谁来都能干活,直接可弃!”

天呐,听了多名业内资深医生的说法,总算知道为啥裁员不裁科研岗,总是先把临床岗位的医生优化掉了,看来不懂点科研,真的很容易最先被淘汰。

不搞科研,首先被裁,你会搞科研吗?

站在国家、医院、个人角度,科研的地位都很高!

现在的医院真的很奇怪,一个医生,就算不懂临床、不会看病,好像也不会怎么着。甚至有些医院如果引进了博士,似乎就没打算让他去看病。现在的风气是医院招的博士越多越好,既能充当门面,又能给医院发文章提高综合排名、赚经费。在院领导眼里,一线临床医生干的那些苦力活是最没有技术含量的活,和科研大佬帮医院发SCI来说,最不值得一提。

风气如此,笔者为临床岗的医生叫屈:难道不搞科研的医生,就要第一批被优化吗?不想搞科研,只想干临床,这还有错了吗?

图片

130日,知名博主潘医生发长文质问,在题目为在医院工作20了,不搞科研可能被裁,你搞吗?的文章中,他指出,现在每个科室都得裁一定比例的人员,从没有科研成果的医生开始。当年大家都以为医院是旱涝保收的,饿不死也吃不撑,为了这铁饭碗,当年学了医,比其他高中同学都苦,学习周期特别长,休息时间特别少,结果辛苦工作20年,就因为不搞科研、没有项目和基金,就面临被优化的风险,搁谁受得了?

图片

在文中,潘医生无奈摊手,他总结道:医院也是自负盈亏的,经济下行时,降本增效都是常规路数,少养一些人,人均工作负荷加大,工作也是能干下来的。在一定要裁人的情况下,试问,裁了谁既能把眼前的活干了,又能给医院留有未来呢?对于省部级医院,国家考核或评级的一大关键指标是科研成果,所以,只能裁不搞科研、只干临床的医生,只会大量留下复合型人才,即啥都能干,临床科研两手抓的医生,这样才能既抗得住眼前的困难,又能展望未来。

在人工智能一周一变样、一月一更迭的当下,不搞科研的医生确实处境更加艰难了。

在前两年的《政府工作报告》中,篇幅高达600多字阐述了一个主题——加快建设创新型国家。内容涵盖3个方面:加强国家创新体系建设;落实和完善创新激励政策;促进万众创新迈上高水平。可以说,科技创新和科研管理正迎来如火如荼的新征程。

对于一个医院来说,医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。

另外,我国的职称晋升也存在着用科研论文作为衡量标准的现象,并且对科研论文的发表质量要求也越来越高,这些因素都使得科研成为医生的刚性需求

无论是站在宏观大局的角度,还是站在医院的角度,又或是站在个人的角度,医生不搞科研,真的没有一点竞争力,遇到裁员这种事都要先挡上去,实在过于悲催。

对于40多岁的医生,根本没有科研的机会了

科研经费来之不易,请好好使用!

不搞科研,有被裁员的风险,可是对于那些40多岁的医生,还怎么搞得了呀?根本没有机会了!

目前,所有国家级科研项目都向青年倾斜,人到中年毫无机会。

例如,男性申请国自然青年项目(青C)需在35岁以下(女性40岁),优青(青B38岁以下(女性40岁),杰青(青A45岁以下(女性48岁)。医院招聘的多为硕士、博士,博士入职已30岁出头,硕士26岁上下。若先专注临床,很可能错过申报“国青”的窗口,但若先成家育儿,数年后重拾科研将异常艰难。且不论早期育儿期间睡眠不良对于体力、精力甚至智力的影响,在孩子稍大后要在孩子教育、临床与科研三者间拉扯对常人是巨大的考验。

因此,科研和临床两手抓还是很困难的,部分医生只能舍弃一方,现在医疗行情不好了,裁员先裁不搞科研的,对于那些只专注于临床的医生来说太不公平了。

另外,业内人士指出,医疗行业如果真看重科研,真想搞出成果,那就务实一点,需要杀一杀科研经费里面的大噱头。那么,这个大噱头到底指什么呢?

此前据多家媒体报道,某高校一名教授花了18亿养猪,科研经费被花得不明不白,这就是科研经费中的“大噱头”。

该教授山竹醇喂猪,每公斤猪饲料添加200毫克的山竹醇,而每头猪一天消耗2.7公斤的饲料,每头猪的成本竟然高达43.2万元。而据学生提供的最新举报证据显示,该教授养了一群,花费账目显示竟然达到18亿,但是却没有科研成果。18个亿的经费花得不明不白,也不知流向了何处。

随后,该教授黄某被学生群体举报,被指学术不端,贪污经费。

在后来的官方回应中,官方证实了举报的真实性,初步认定黄某存在学术不端行为,并宣布停止其在校内的一切职务和工作。

在医疗科研中,像上文中的类似案件很多,科研经费申请下来后被花得不明不白,甚至各种噱头,医院重视科研工作这没错,但是经费申请下来后,请好好使用这笔钱,不然,无论再怎么大喊科研的重要性,都只会让人感到无感。

评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    15小时前 1212ad1cm87暂无昵称 来自吉林省
  2. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    15小时前 ms4000000512201075 来自吉林省
  3. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    昨天 baiwenxiu_6586 来自山西省
  4. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    2026-02-16 baiwenxiu_6586 来自山西省
  5. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    2026-02-16 1212ad1cm87暂无昵称 来自吉林省
  6. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    2026-02-16 ms4000000512201075 来自吉林省
  7. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    2026-02-15 ms1000001746701033 来自吉林省
  8. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    2026-02-15 ms4000000512201075 来自吉林
  10. [GetPortalCommentsPageByObjectIdResponse(id=2300920, encodeId=41ef230092013, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Tue Feb 17 16:02:37 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300917, encodeId=ad18230091e4e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Tue Feb 17 16:00:24 CST 2026, time=15小时前, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300880, encodeId=3cec230088059, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Tue Feb 17 07:22:45 CST 2026, time=昨天, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300865, encodeId=4c4d23008653e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Mon Feb 16 14:29:10 CST 2026, time=2026-02-16, status=0, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2300857, encodeId=7ea7230085e73, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Mon Feb 16 07:28:20 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300855, encodeId=a39a23008554e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Mon Feb 16 07:23:52 CST 2026, time=2026-02-16, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300793, encodeId=86772300e9315, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a69779352, createdName=ms1000001746701033, createdTime=Sun Feb 15 19:41:29 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2300791, encodeId=0c5e2300e918e, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00332233446, createdName=1212ad1cm87暂无昵称, createdTime=Sun Feb 15 19:23:18 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300789, encodeId=e8892300e89e0, content=前往app查看评论内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sun Feb 15 19:21:12 CST 2026, time=2026-02-15, status=0, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2300708, encodeId=56f52300e08e8, content=医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb76152142, createdName=baiwenxiu_6586, createdTime=Sat Feb 14 09:37:54 CST 2026, time=2026-02-14, status=1, ipAttribution=山西省)]
    2026-02-14 baiwenxiu_6586 来自山西省

    医学科学研究的含义是使用先进的科学技术手段,重点解决临床工作中的实际问题,这是医院学科建设和人才培养的重要手段,是医院持续、稳步、快速发展的最有力保障。

    0